These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85. Re: Ophthalmic complications following ocular penetration during routine dentistry in 13 cats. Forsayeth A N Z Vet J; 2019 May; 67(3):159-160. PubMed ID: 30570373 [No Abstract] [Full Text] [Related]
86. Retinal Delivery of the Protein Kinase C-β Inhibitor Ruboxistaurin Using Non-Invasive Nanoparticles of Polyamidoamine Dendrimers. Alshammari RA; Aleanizy FS; Aldarwesh A; Alqahtani FY; Mahdi WA; Alquadeib B; Alqahtani QH; Haq N; Shakeel F; Abdelhady HG; Alsarra IA Pharmaceutics; 2022 Jul; 14(7):. PubMed ID: 35890338 [TBL] [Abstract][Full Text] [Related]
87. Penetration of topically administered dexamethasone disodium phosphate and prednisolone acetate into the normal equine ocular fluids. Hermans H; van den Berg EMH; Slenter IJM; Vendrig DJC; de Nijs-Tjon LJL; Vernooij JCM; Brommer H; Boevé MH; Gehring R Equine Vet J; 2022 Sep; 54(5):965-972. PubMed ID: 34706129 [TBL] [Abstract][Full Text] [Related]
88. Tissue distribution of dexamethasone in canine ocular compartments following topical application of dexamethasone-21-isonicotinate and oxytetracycline HCl. Kaiser T; Werner A; Bäumer W; Kietzmann M Vet Ophthalmol; 2008; 11(5):335-9. PubMed ID: 19046294 [TBL] [Abstract][Full Text] [Related]
89. AL-2512, a novel corticosteroid: preclinical assessment of anti-inflammatory and ocular hypertensive effects. Bhattacherjee P; Mukhopadhyay P; Paterson CA; Graff G; Gamache DA; Yanni JM J Ocul Pharmacol Ther; 2003 Aug; 19(4):353-60. PubMed ID: 12964959 [TBL] [Abstract][Full Text] [Related]
90. Cyclodextrin microparticles for drug delivery to the posterior segment of the eye: aqueous dexamethasone eye drops. Loftsson T; Hreinsdóttir D; Stefánsson E J Pharm Pharmacol; 2007 May; 59(5):629-35. PubMed ID: 17524227 [TBL] [Abstract][Full Text] [Related]
91. Ocular distribution, bactericidal activity and settling characteristics of TobraDex ST ophthalmic suspension compared with TobraDex ophthalmic suspension. Scoper SV; Kabat AG; Owen GR; Stroman DW; Kabra BP; Faulkner R; Kulshreshtha AK; Rusk C; Bell B; Jamison T; Bernal-Perez LF; Brooks AC; Nguyen VA Adv Ther; 2008 Feb; 25(2):77-88. PubMed ID: 18309465 [TBL] [Abstract][Full Text] [Related]
92. Tissue distribution of dexamethasone in feline ocular structures following single topical application of dexamethasone as an ointment or suspension. Bessonova J; Meyer-Lindenberg A; Bäumer W; Kietzmann M Vet Ophthalmol; 2011 Mar; 14(2):109-13. PubMed ID: 21366826 [TBL] [Abstract][Full Text] [Related]
93. New quinolone/steroid combination for topical treatment of acute otitis: early- and late-phase study results. Conroy PJ Ear Nose Throat J; 2003 Aug; 82(8 Suppl 2):2-4. PubMed ID: 12974049 [No Abstract] [Full Text] [Related]
94. Ciprofloxacin 0.3%/dexamethasone 0.1% sterile otic suspension for the topical treatment of ear infections: a review of the literature. Wall GM; Stroman DW; Roland PS; Dohar J Pediatr Infect Dis J; 2009 Feb; 28(2):141-4. PubMed ID: 19116600 [TBL] [Abstract][Full Text] [Related]